Intuitive Surgical, Inc. (NASDAQ:ISRG) Stake Cut by Inspire Investing LLC

Inspire Investing LLC lowered its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.7% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 32,491 shares of the medical equipment provider’s stock after selling 227 shares during the period. Intuitive Surgical makes up 1.9% of Inspire Investing LLC’s investment portfolio, making the stock its 2nd largest position. Inspire Investing LLC’s holdings in Intuitive Surgical were worth $16,959,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of ISRG. LVW Advisors LLC raised its holdings in shares of Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after buying an additional 19 shares in the last quarter. Wesbanco Bank Inc. raised its holdings in shares of Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after buying an additional 19 shares in the last quarter. Hazlett Burt & Watson Inc. raised its holdings in shares of Intuitive Surgical by 5.8% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock valued at $177,000 after buying an additional 20 shares in the last quarter. Mitchell Mcleod Pugh & Williams Inc. raised its holdings in shares of Intuitive Surgical by 4.1% during the 3rd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock valued at $247,000 after buying an additional 20 shares in the last quarter. Finally, Fragasso Financial Advisors Inc raised its holdings in shares of Intuitive Surgical by 3.0% during the 4th quarter. Fragasso Financial Advisors Inc now owns 687 shares of the medical equipment provider’s stock valued at $359,000 after buying an additional 20 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 1.0 %

NASDAQ ISRG opened at $610.45 on Thursday. The stock’s 50 day moving average is $544.61 and its 200 day moving average is $502.64. The firm has a market capitalization of $217.43 billion, a PE ratio of 98.14, a P/E/G ratio of 5.13 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $362.14 and a twelve month high of $614.72.

Insider Activity

In related news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction that occurred on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total transaction of $95,225.76. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,788,899.12. This trade represents a 3.30 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Jamie Samath sold 270 shares of the business’s stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 43,487 shares of company stock worth $22,590,975. Corporate insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on ISRG shares. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Royal Bank of Canada raised their price target on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research report on Friday, October 18th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Finally, Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.